Welcome to LookChem.com Sign In|Join Free

CAS

  • or

494-97-3

Post Buying Request

494-97-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

494-97-3 Usage

Chemical Properties

Pale Yellow to Reddish Brown Oil

Uses

Different sources of media describe the Uses of 494-97-3 differently. You can refer to the following data:
1. (S)-Nornicotine is a metabolite of Nicotine (N412420). Can catalyze aqueous aldol reactions.
2. Agricultural or horticultural insecticide.

Definition

ChEBI: A pyridine alkaloid that is nicotine lacking the methyl group on the pyrrolidine nitrogen.

Safety Profile

Poison by intraperitoneal andintravenous routes. About 1/3 the toxicity of nicotine.Causes faintness, prostration, muscular weakness, severenausea, vomiting, diarrhea, and collapse withoutconvulsions. An insecticide. When heated todecomposition it em

Check Digit Verification of cas no

The CAS Registry Mumber 494-97-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,9 and 4 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 494-97:
(5*4)+(4*9)+(3*4)+(2*9)+(1*7)=93
93 % 10 = 3
So 494-97-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H12N2/c1-3-8(7-10-5-1)9-4-2-6-11-9/h1,3,5,7,9,11H,2,4,6H2

494-97-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name nornicotine

1.2 Other means of identification

Product number -
Other names Pyridine, 3-(2-pyrrolidinyl)-, (S)-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:494-97-3 SDS

494-97-3Synthetic route

(S)-1-(2,3,4,6-Tetra-O-pivaloyl-β-D-galactopyranosyl)-2-(3-pyridyl)pyrrolidine
252005-64-4

(S)-1-(2,3,4,6-Tetra-O-pivaloyl-β-D-galactopyranosyl)-2-(3-pyridyl)pyrrolidine

A

2,3,4,6-Tetra-O-pivaloyl-α/β-D-galactopyranose
135865-76-8, 135865-81-5, 144102-44-3, 148968-87-0, 150737-36-3

2,3,4,6-Tetra-O-pivaloyl-α/β-D-galactopyranose

B

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
In hydrogenchloride; methanol Hydrolysis;A n/a
B 95%
(S)-3-(1-azido-but-3-enyl)pyridine
314280-29-0

(S)-3-(1-azido-but-3-enyl)pyridine

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
With bis(cyclohexanyl)borane In tetrahydrofuran at -15 - 20℃; for 12h;85%
(S)-5-bromonornicotine (R)-(+)-α-methoxy-α-trifluoromethylphenyl acetic acid salt

(S)-5-bromonornicotine (R)-(+)-α-methoxy-α-trifluoromethylphenyl acetic acid salt

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
Stage #1: (S)-5-bromonornicotine (R)-(+)-α-methoxy-α-trifluoromethylphenyl acetic acid salt With potassium hydroxide In water for 1h;
Stage #2: With palladium 10% on activated carbon; hydrogen; triethylamine In ethanol at 20℃;
69%
rac-nornicotine
5746-86-1

rac-nornicotine

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
With borane-ammonia complex; 6-hydroxy-D-nicotine oxidase E350L/E352D mutant for 28h; Kinetics; Enzymatic reaction; enantioselective reaction;60%
With 6,6′-dinitro[1,1′-biphenyl]-2,2′-dicarboxylic acid
nicotin
54-11-5

nicotin

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
bioconversion, by cell suspension of Nicotiana plumbaginifolia;53.2%
With potassium permanganate
With water; silver(l) oxide
(S)-5-bromonornicotine (+)-MTPA

(S)-5-bromonornicotine (+)-MTPA

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
Stage #1: (S)-5-bromonornicotine (+)-MTPA With potassium hydroxide In diethyl ether
Stage #2: With palladium 10% on activated carbon; hydrogen; triethylamine In ethanol for 1h;
53%
rac-nornicotine
5746-86-1

rac-nornicotine

A

nornicotine
494-97-3

nornicotine

B

(+)-nornicotine
7076-23-5

(+)-nornicotine

Conditions
ConditionsYield
With Chiralpak AD-H In methanol; N,N-dimethyl-ethanamine Resolution of racemate;A 30%
B 25%
nicotin
54-11-5

nicotin

A

nornicotine
494-97-3

nornicotine

B

S-(-)-Norcotinine
5980-06-3

S-(-)-Norcotinine

C

cotinine
486-56-6

cotinine

Conditions
ConditionsYield
With air; cofactor solution; phenobarbitone-induced rabbit hepatic homogenate In phosphate buffer at 37℃; for 1h; pH=7.4; Oxidation; demethylation; Further byproducts given;A 15.9%
B n/a
C 27.5%
D n/a
(S)-5-bromo-3-(1H-2-pyrrolidinyl)pyridine
83023-58-9

(S)-5-bromo-3-(1H-2-pyrrolidinyl)pyridine

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
With triethylamine; palladium on activated charcoal In ethanol under 760 Torr; for 1h; Yield given;
With hydrogen
With hydrogen; triethylamine; palladium on activated charcoal In ethanol under 760.051 Torr; for 1h;621 mg
nicotin
54-11-5

nicotin

A

N-methylmyosmine
525-74-6

N-methylmyosmine

B

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
In water at 28℃; for 120h; Product distribution; Cunninghamella echinulata IFO-4444; other times, other fungi;
nicotin
54-11-5

nicotin

A

N-formyl-2-(3-pyridyl)pyrrolidine
38840-03-8

N-formyl-2-(3-pyridyl)pyrrolidine

B

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
at 25℃; Nicotiana tabacum L. cv Wisconsin-38;
1-(N-methyl)-1,5-pentanediamine
32752-52-6

1-(N-methyl)-1,5-pentanediamine

A

N-methylanabasine
24380-92-5

N-methylanabasine

B

nornicotine
494-97-3

nornicotine

C

nicotin
54-11-5

nicotin

D

anatabine
581-49-7

anatabine

Conditions
ConditionsYield
With Nicotiana rustica Condensation; Enzymatic reaction; Further byproducts given;
N-ethylcadaverine
258818-11-0

N-ethylcadaverine

A

N-ethylanabasine
68245-76-1

N-ethylanabasine

B

nornicotine
494-97-3

nornicotine

C

nicotin
54-11-5

nicotin

D

anatabine
581-49-7

anatabine

Conditions
ConditionsYield
With Nicotiana rustica Condensation; Enzymatic reaction; Further byproducts given;
N-(4-aminobutyl)propylamine
70862-18-9

N-(4-aminobutyl)propylamine

A

nornicotine
494-97-3

nornicotine

B

nicotin
54-11-5

nicotin

C

anatabine
581-49-7

anatabine

D

N'-Propylnornicotine

N'-Propylnornicotine

Conditions
ConditionsYield
With Nicotiana rustica Condensation; Enzymatic reaction; Further byproducts given;
N-(4-aminobutyl)butylamine
70862-19-0

N-(4-aminobutyl)butylamine

A

nornicotine
494-97-3

nornicotine

B

nicotin
54-11-5

nicotin

C

anatabine
581-49-7

anatabine

D

N-n-butylnornicotine

N-n-butylnornicotine

Conditions
ConditionsYield
With Nicotiana rustica Condensation; Enzymatic reaction; Further byproducts given;
N-propylcadaverine

N-propylcadaverine

A

N-propylanabasine
68245-77-2

N-propylanabasine

B

nornicotine
494-97-3

nornicotine

C

nicotin
54-11-5

nicotin

D

anatabine
581-49-7

anatabine

Conditions
ConditionsYield
With Nicotiana rustica Condensation; Enzymatic reaction; Further byproducts given;
5-bromopyridine-3-carbaldehyde
113118-81-3

5-bromopyridine-3-carbaldehyde

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 97 percent / Zn / tetrahydrofuran / 1 h / 20 °C
2: 100 percent / DMP / CH2Cl2 / 0.5 h / 20 °C
3: (+)-B-chlorodiisopinocampheylborane / tetrahydrofuran / -30 °C
4: 100 percent / Et3N / CH2Cl2 / 0.17 h / 0 °C
5: 83 percent / NaN3 / dimethylformamide / 4 h / 60 °C
6: 62 percent / cyclohexene; BH3*Me2S / tetrahydrofuran / 12 h / -15 - 20 °C
7: H2
View Scheme
Multi-step reaction with 6 steps
1.1: DMP / CH2Cl2
1.2: tetrahydrofuran
2.1: (+)-B-chlorodiisopinocampheylborane / tetrahydrofuran / -30 °C
3.1: 100 percent / Et3N / CH2Cl2 / 0.17 h / 0 °C
4.1: 83 percent / NaN3 / dimethylformamide / 4 h / 60 °C
5.1: 62 percent / cyclohexene; BH3*Me2S / tetrahydrofuran / 12 h / -15 - 20 °C
6.1: H2
View Scheme
Multi-step reaction with 5 steps
1: diethyl ether / 1 h / -100 °C
2: 100 percent / Et3N / CH2Cl2 / 0.17 h / 0 °C
3: 83 percent / NaN3 / dimethylformamide / 4 h / 60 °C
4: 62 percent / cyclohexene; BH3*Me2S / tetrahydrofuran / 12 h / -15 - 20 °C
5: H2
View Scheme
5-bromo-3-pyridinecarboxylic acid
20826-04-4

5-bromo-3-pyridinecarboxylic acid

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1.1: DMF; oxalyl chloride / acetonitrile; tetrahydrofuran; pyridine / 1.5 h / -30 °C
1.2: 63 percent / CuI; tri-tert-butoxyaluminium hydride / acetonitrile; tetrahydrofuran; pyridine / 0.25 h / -78 °C
2.1: 97 percent / Zn / tetrahydrofuran / 1 h / 20 °C
3.1: 100 percent / DMP / CH2Cl2 / 0.5 h / 20 °C
4.1: (+)-B-chlorodiisopinocampheylborane / tetrahydrofuran / -30 °C
5.1: 100 percent / Et3N / CH2Cl2 / 0.17 h / 0 °C
6.1: 83 percent / NaN3 / dimethylformamide / 4 h / 60 °C
7.1: 62 percent / cyclohexene; BH3*Me2S / tetrahydrofuran / 12 h / -15 - 20 °C
8.1: H2
View Scheme
Multi-step reaction with 7 steps
1.1: DMF; oxalyl chloride / acetonitrile; tetrahydrofuran; pyridine / 1.5 h / -30 °C
1.2: 63 percent / CuI; tri-tert-butoxyaluminium hydride / acetonitrile; tetrahydrofuran; pyridine / 0.25 h / -78 °C
2.1: DMP / CH2Cl2
2.2: tetrahydrofuran
3.1: (+)-B-chlorodiisopinocampheylborane / tetrahydrofuran / -30 °C
4.1: 100 percent / Et3N / CH2Cl2 / 0.17 h / 0 °C
5.1: 83 percent / NaN3 / dimethylformamide / 4 h / 60 °C
6.1: 62 percent / cyclohexene; BH3*Me2S / tetrahydrofuran / 12 h / -15 - 20 °C
7.1: H2
View Scheme
Multi-step reaction with 6 steps
1.1: DMF; oxalyl chloride / acetonitrile; tetrahydrofuran; pyridine / 1.5 h / -30 °C
1.2: 63 percent / CuI; tri-tert-butoxyaluminium hydride / acetonitrile; tetrahydrofuran; pyridine / 0.25 h / -78 °C
2.1: diethyl ether / 1 h / -100 °C
3.1: 100 percent / Et3N / CH2Cl2 / 0.17 h / 0 °C
4.1: 83 percent / NaN3 / dimethylformamide / 4 h / 60 °C
5.1: 62 percent / cyclohexene; BH3*Me2S / tetrahydrofuran / 12 h / -15 - 20 °C
6.1: H2
View Scheme
1-(5-bromopyridin-3-yl)but-3-en-1-ol
360767-43-7

1-(5-bromopyridin-3-yl)but-3-en-1-ol

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 100 percent / DMP / CH2Cl2 / 0.5 h / 20 °C
2: (+)-B-chlorodiisopinocampheylborane / tetrahydrofuran / -30 °C
3: 100 percent / Et3N / CH2Cl2 / 0.17 h / 0 °C
4: 83 percent / NaN3 / dimethylformamide / 4 h / 60 °C
5: 62 percent / cyclohexene; BH3*Me2S / tetrahydrofuran / 12 h / -15 - 20 °C
6: H2
View Scheme
1-(5-bromopyridin-3-yl)but-3-en-1-one
360767-46-0

1-(5-bromopyridin-3-yl)but-3-en-1-one

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: (+)-B-chlorodiisopinocampheylborane / tetrahydrofuran / -30 °C
2: 100 percent / Et3N / CH2Cl2 / 0.17 h / 0 °C
3: 83 percent / NaN3 / dimethylformamide / 4 h / 60 °C
4: 62 percent / cyclohexene; BH3*Me2S / tetrahydrofuran / 12 h / -15 - 20 °C
5: H2
View Scheme
(R)-1-(5-bromopyridin-3-yl)but-3-en-1-ol
360767-40-4

(R)-1-(5-bromopyridin-3-yl)but-3-en-1-ol

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 100 percent / Et3N / CH2Cl2 / 0.17 h / 0 °C
2: 83 percent / NaN3 / dimethylformamide / 4 h / 60 °C
3: 62 percent / cyclohexene; BH3*Me2S / tetrahydrofuran / 12 h / -15 - 20 °C
4: H2
View Scheme
(S)-3-(1-azidobut-3-enyl)-5-bromopyridine
360767-36-8

(S)-3-(1-azidobut-3-enyl)-5-bromopyridine

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 62 percent / cyclohexene; BH3*Me2S / tetrahydrofuran / 12 h / -15 - 20 °C
2: H2
View Scheme
(R)-methanesulfonic acid 1-(5-bromopyridin-3-yl)but-3-enyl ester
360767-38-0

(R)-methanesulfonic acid 1-(5-bromopyridin-3-yl)but-3-enyl ester

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 83 percent / NaN3 / dimethylformamide / 4 h / 60 °C
2: 62 percent / cyclohexene; BH3*Me2S / tetrahydrofuran / 12 h / -15 - 20 °C
3: H2
View Scheme
3-pyridinecarboxaldehyde
500-22-1

3-pyridinecarboxaldehyde

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: tetrahydrofuran / 1 h / -100 °C
2: 100 percent / Et3N / CH2Cl2 / 0.17 h / 0 °C
3: 97 percent / NaN3 / dimethylformamide / 4 h / 60 °C
4: 85 percent / dicyclohexylborane / tetrahydrofuran / 12 h / -15 - 20 °C
View Scheme
Multi-step reaction with 3 steps
1: tetrahydrofuran / 1 h / -100 °C
2: 88 percent / diphenylphosphorylazide; DBU / toluene / 72 h / 20 °C
3: 85 percent / dicyclohexylborane / tetrahydrofuran / 12 h / -15 - 20 °C
View Scheme
(R)-1-(pyridin-3-yl)but-3-en-1-ol
314280-28-9

(R)-1-(pyridin-3-yl)but-3-en-1-ol

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 100 percent / Et3N / CH2Cl2 / 0.17 h / 0 °C
2: 97 percent / NaN3 / dimethylformamide / 4 h / 60 °C
3: 85 percent / dicyclohexylborane / tetrahydrofuran / 12 h / -15 - 20 °C
View Scheme
Multi-step reaction with 2 steps
1: 88 percent / diphenylphosphorylazide; DBU / toluene / 72 h / 20 °C
2: 85 percent / dicyclohexylborane / tetrahydrofuran / 12 h / -15 - 20 °C
View Scheme
(R)-methanesulfonic acid 1-pyridin-3-yl-but-3-enyl ester
372519-16-9

(R)-methanesulfonic acid 1-pyridin-3-yl-but-3-enyl ester

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 97 percent / NaN3 / dimethylformamide / 4 h / 60 °C
2: 85 percent / dicyclohexylborane / tetrahydrofuran / 12 h / -15 - 20 °C
View Scheme
4-(3-pyridyl)-4-oxobutanol
59578-62-0

4-(3-pyridyl)-4-oxobutanol

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: 82 percent / (COCl)2; NEt3 / dimethylsulfoxide
2.1: molecular sieves 4 Angstroem / CH2Cl2 / 16 h / 20 °C
2.2: 45 percent / NaCNBH3 / methanol; acetic acid / 16 h / 0 - 20 °C
3.1: 95 percent / aq. HCl; methanol
View Scheme
4-Oxo-1-(3-pyridyl)-1-butanone
76014-80-7

4-Oxo-1-(3-pyridyl)-1-butanone

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: molecular sieves 4 Angstroem / CH2Cl2 / 16 h / 20 °C
1.2: 45 percent / NaCNBH3 / methanol; acetic acid / 16 h / 0 - 20 °C
2.1: 95 percent / aq. HCl; methanol
View Scheme
ethyl 5-bromo-3-pyridinecarboxylate
20986-40-7

ethyl 5-bromo-3-pyridinecarboxylate

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
2: 79 percent / NaBH4 / methanol; acetic acid / -40 - -20 °C
4: Et3N / 10percent Pd/C / ethanol / 1 h / 760 Torr
View Scheme
Multi-step reaction with 3 steps
1.1: sodium hydride / tetrahydrofuran
2.1: sodium tetrahydroborate; acetic acid; methanol
2.2: Resolution of racemate
3.1: potassium hydroxide / diethyl ether
View Scheme
Multi-step reaction with 4 steps
1.1: sodium hydride / mineral oil; hexane; tetrahydrofuran / 1 h / Reflux; Inert atmosphere
1.2: Reflux
2.1: acetic acid; sodium tetrahydroborate / methanol; acetonitrile / 0.17 h / -40 - 20 °C
3.1: ethyl acetate / 0.25 h
4.1: potassium hydroxide / diethyl ether
4.2: 1 h
View Scheme
Multi-step reaction with 4 steps
1.1: sodium hydride / mineral oil; tetrahydrofuran / 1 h / Reflux; Inert atmosphere
1.2: Reflux; Inert atmosphere
2.1: acetic acid; sodium tetrahydroborate / methanol / 0.5 h / -40 - 20 °C
3.1: ethyl acetate / 0.25 h / 20 °C
4.1: potassium hydroxide / water / 1 h
4.2: 20 °C
View Scheme
5-Bromo-3-(2-pyrrolidinyl)pyridine
71719-06-7

5-Bromo-3-(2-pyrrolidinyl)pyridine

nornicotine
494-97-3

nornicotine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
2: Et3N / 10percent Pd/C / ethanol / 1 h / 760 Torr
View Scheme
Multi-step reaction with 2 steps
1.1: ethyl acetate / 0.25 h
2.1: potassium hydroxide / diethyl ether
2.2: 1 h
View Scheme
Multi-step reaction with 2 steps
1.1: ethyl acetate / 0.25 h / 20 °C
2.1: potassium hydroxide / water / 1 h
2.2: 20 °C
View Scheme
methyl 4-iodobutanoate
14273-85-9

methyl 4-iodobutanoate

nornicotine
494-97-3

nornicotine

(S)-methyl 4-(2-(pyridin-3-yl)pyrrolidin-1-yl)butanoate

(S)-methyl 4-(2-(pyridin-3-yl)pyrrolidin-1-yl)butanoate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 18h;78%
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 18h;78%
methyl 6-iodohexanoate
14273-91-7

methyl 6-iodohexanoate

nornicotine
494-97-3

nornicotine

(S)-methyl 6-(2-(pyridin-3-yl)pyrrolidin-1-yl)hexanoate

(S)-methyl 6-(2-(pyridin-3-yl)pyrrolidin-1-yl)hexanoate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 18h;75%
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 18h;75%
4-(4-bromo-2-chloro-phenoxy)-benzaldehyde
1040051-31-7

4-(4-bromo-2-chloro-phenoxy)-benzaldehyde

nornicotine
494-97-3

nornicotine

C22H20BrClN2O

C22H20BrClN2O

Conditions
ConditionsYield
With sodium tris(acetoxy)borohydride; acetic acid In 1,2-dichloro-ethane at 20℃; for 15h; Inert atmosphere;74%
methyl trans-γ-iodocrotonate
65495-78-5

methyl trans-γ-iodocrotonate

nornicotine
494-97-3

nornicotine

methyl (E)-4-((S)-2-(pyridin-3-yl)pyrrolidin-1-yl)but-2-enoate

methyl (E)-4-((S)-2-(pyridin-3-yl)pyrrolidin-1-yl)but-2-enoate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 18h;73%
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 18h;73%
3-chloro-4-(4-formylphenoxy)benzamide
676494-59-0

3-chloro-4-(4-formylphenoxy)benzamide

nornicotine
494-97-3

nornicotine

(S)-3-chloro-4-(4-((2-(pyridin-3-yl)pyrrolidin-1-yl)methyl)phenoxy)benzamide
1346133-08-1

(S)-3-chloro-4-(4-((2-(pyridin-3-yl)pyrrolidin-1-yl)methyl)phenoxy)benzamide

Conditions
ConditionsYield
With sodium tris(acetoxy)borohydride; acetic acid In 1,2-dichloro-ethane at 20℃;68%
(6-iodohexyl)-carbamic acid 1,1-dimethylethyl ester
172846-36-5

(6-iodohexyl)-carbamic acid 1,1-dimethylethyl ester

nornicotine
494-97-3

nornicotine

[6-[(2S)-2-(3-pyridinyl)-1-pyrrolidinyl]hexyl]-carbamic acid 1,1-dimethylethyl ester
350820-82-5

[6-[(2S)-2-(3-pyridinyl)-1-pyrrolidinyl]hexyl]-carbamic acid 1,1-dimethylethyl ester

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 15h;59%
benzyl 4-iodobutanoate
118058-69-8

benzyl 4-iodobutanoate

nornicotine
494-97-3

nornicotine

(2S)-2-(3-pyridinyl)-1-pyrrolidinebutanoic acid phenylmethyl ester
350820-86-9

(2S)-2-(3-pyridinyl)-1-pyrrolidinebutanoic acid phenylmethyl ester

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃;58%
N-(tert-butoxycarbonyl)piperidine-4-carboxylic acid N-(4-iodobutyl)amide

N-(tert-butoxycarbonyl)piperidine-4-carboxylic acid N-(4-iodobutyl)amide

nornicotine
494-97-3

nornicotine

N-(tert-butoxycarbonyl)piperidine-4-carboxylic acid N-(4-((S)-2-(pyridin-3-yl)pyrrolidin-1-yl)butyl)amide

N-(tert-butoxycarbonyl)piperidine-4-carboxylic acid N-(4-((S)-2-(pyridin-3-yl)pyrrolidin-1-yl)butyl)amide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 18h;51%
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 18h;51%
tert-butyl 4-((5-iodopentyl)carbamoyl)piperidine-1-carboxylate

tert-butyl 4-((5-iodopentyl)carbamoyl)piperidine-1-carboxylate

nornicotine
494-97-3

nornicotine

(S)-tert-butyl 4-((5-(2-(pyridin-3-yl)pyrrolidin-1-yl)pentyl)carbamoyl)piperidine-1-carboxylate

(S)-tert-butyl 4-((5-(2-(pyridin-3-yl)pyrrolidin-1-yl)pentyl)carbamoyl)piperidine-1-carboxylate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 18h;49%

494-97-3Relevant articles and documents

Method for synthesizing chiral nicotine from butyrolactone

-

Paragraph 0057-0059, (2021/11/03)

The invention discloses a method for synthesizing chiral nicotine from butyrolactone. The fumarates and γ - butyrolactone are condensed under the action of a basic catalyst to yield 4 - chloro -1 - (3 - pyridine) -1 -butanone by reaction with hydrochloric acid and reacted with a chlorination reagent to produce (- B -) S (-4 -1 -dichlorobutyl) pyridine which is reacted with an amine reagent under basic conditions to give (-3 -) -1 -methyl nicotine and (S)-3 - nicotinic acetylbutanolamines obtained by the reaction with the aminating reagent under an alkaline condition to produce a chiral hydroxy S S group - (1) S- methylnicotine or a (4 -) S nicotinic acid. The application can determine whether a methylation reaction is needed according to the type of amination reagent. The yield of (S)- nicotine was high.

Orthogonal Catalysis for an Enantioselective Domino Inverse-Electron Demand Diels?Alder/Substitution Reaction

Ahles, Sebastian,Beeck, Sebastian,Wegner, Hermann A.

supporting information, (2021/12/09)

An enantioselective domino process for the synthesis of substituted 1,2-dihydronaphthalenes has been developed by the combination of chiral amines and a bidentate Lewis acid in an orthogonal catalysis. This new method is based on an inverse electron-demand Diels?Alder and a subsequent group exchange reaction. An enamine is generated in situ from an aldehyde and a chiral secondary amine catalyst that reacts with phthalazine, activated by the coordination to a bidentate Lewis acid catalyst. The absolute configuration of the product is controlled by chiral information provided by the amine. The formed ortho-quinodimethane intermediate is then transformed via a group exchange reaction with thiols. The new method shows a broad scope and tolerates a wide range of functional groups with enantiomeric ratios up to 91 : 9. All-in-all, this enantioselective synthesis tool provides an easy access to complex 1,2-dihydronaphthalenes starting from readily available phthalazine, aldehydes and thiols in a combinatorial way.

Evaluation of the Edman degradation product of vancomycin bonded to core-shell particles as a new HPLC chiral stationary phase

Hellinghausen, Garrett,Lopez, Diego A.,Lee, Jauh T.,Wang, Yadi,Weatherly, Choyce A.,Portillo, Abiud E.,Berthod, Alain,Armstrong, Daniel W.

, p. 1067 - 1078 (2018/08/01)

A modified macrocyclic glycopeptide-based chiral stationary phase (CSP), prepared via Edman degradation of vancomycin, was evaluated as a chiral selector for the first time. Its applicability was compared with other macrocyclic glycopeptide-based CSPs: TeicoShell and VancoShell. In addition, another modified macrocyclic glycopeptide-based CSP, NicoShell, was further examined. Initial evaluation was focused on the complementary behavior with these glycopeptides. A screening procedure was used based on previous work for the enantiomeric separation of 50 chiral compounds including amino acids, pesticides, stimulants, and a variety of pharmaceuticals. Fast and efficient chiral separations resulted by using superficially porous (core-shell) particle supports. Overall, the vancomycin Edman degradation product (EDP) resembled TeicoShell with high enantioselectivity for acidic compounds in the polar ionic mode. The simultaneous enantiomeric separation of 5 racemic profens using liquid chromatography-mass spectrometry with EDP was performed in approximately 3?minutes. Other highlights include simultaneous liquid chromatography separations of rac-amphetamine and rac-methamphetamine with VancoShell, rac-pseudoephedrine and rac-ephedrine with NicoShell, and rac-dichlorprop and rac-haloxyfop with TeicoShell.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 494-97-3